Clinical Trial Update: A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on IMMUNOCERV evaluating the PDS0101 vaccine with chemoradiation for locally advanced cervical cancer (Stage IB3-IVA); the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• PDS0101

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB3 Cervical Cancer FIGO 2018 | Phase 2 | Status: ACTIVE_NOT_RECRUITING